Journal Home
Search for

Volume 61, Issue 4, Pages 461-467 (October 2006)


View previous. 9 of 29 View next.

A single session of reassurance can acutely improve the self-perception of impairment in patients with IBS

Max J. SchmulsonaCorresponding Author Informationemail address, Orianna M. Ortiz-Garridob, Carlos Hinojosac, Denise Arcilad

Received 15 June 2005

Abstract 

Objective

The aim of this study was to determine the reported frequency and self-perceived importance of factors related to health care seeking by irritable bowel syndrome (IBS) patients and the effect of reassurance on these factors.

Methods

Fifty-five IBS patients, consulting for the first time, answered a questionnaire designed to evaluate these factors (FRQ), measurements of anxiety, depression, and quality of life (QoL). A thorough explanation of the disease and reassurance were given, and the FRQ was answered again.

Results

The frequency of factors was: pain/discomfort, 78%; cancer fear, 11%; daily function impairment, 33%; symptoms stressfulness, 60%; and none, 2%. Pain/discomfort and symptom stressfulness were considered the most important ones. Cancer fear and symptom stressfulness correlated with anxiety (P=.003, .042), depression (P=.038, .019), and daily function impairment with depression (P=.05). Cancer fear, daily function impairment, and symptom stressfulness impacted on QoL. Reassurance acutely decreased the self-perception of daily function impairment (P=.003), independent of the patient's educational level.

Conclusions

Reassurance during the first consultation for IBS decreased the self-perception of impairment in daily function.

a Department of Experimental Medicine, Faculty of Medicine-Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico

b Department of Internal Medicine, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Mexico City, Mexico

c Department of Surgery, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

d Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Corresponding Author InformationCorresponding author. Laboratory of Liver, Pancreas, and Motility (HIPAM), Department of Experimental Medicine, Faculty of Medicine-Universidad Nacional Autónoma de México (UNAM), Hospital General de México, Doctor Balmis No. 148-Col. Doctores, Del. Cuauhtemoc, Mexico. Tel.: +52 555 623 2683.

PII: S0022-3999(06)00088-2

doi:10.1016/j.jpsychores.2006.02.011


View previous. 9 of 29 View next.